Employer record · Cambridge, MA · FY2025–FY2026
Alkeus Pharmaceuticals, Inc
- Certified LCAs
- 3
- FY2024–FY2026
- USCIS approvals
- 3
- 1 new employment
- Denial rate
- 0.0%
- FY2024–FY2026
- Median wage offered
- $110k
- certified LCAs
Does Alkeus Pharmaceuticals, Inc sponsor H-1B visas?
Yes — by its record, Alkeus Pharmaceuticals, Inc is a small-scale H-1B sponsor: it filed 3 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 3 USCIS H-1B petition approvals (1 for new employment). Its latest certified LCA in our data was decided Feb 9, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.
Top sponsors in Massachusetts →Pharmaceuticals and biotech manufacturing sponsors →Sponsors based in Cambridge →
Filings by fiscal year
Certified LCAs per U.S. government fiscal year (Oct–Sep); the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.
| Fiscal year | certified LCAs | USCIS approvals | Approval rate |
|---|---|---|---|
| FY25 | 2 | 3 | 100% |
| FY26 | 1 | 0 | – |
Occupations sponsored
| Occupation (SOC) | LCAs | Median wage |
|---|---|---|
| Industrial Production Managers 11-3051 | 1 | $193k |
| Project Management Specialists 13-1082 | 1 | $92k |
| Computer Systems Engineers/Architects 15-1299 | 1 | $110k |
Most-filed job titles
- Associate Director, GMP Quality Assurance1$193k
- Senior Associate, Quality Management Systems1$110k
- Project Manager, Medical Affairs1$92k
LCAs per title and median wage offered.
Where the jobs were
- Massachusetts3 LCAs
Open jobs
Get weekly email alerts for new Alkeus Pharmaceuticals jobs
- at Alkeus Pharmaceuticals
Free. One email a week, only when there are new matches. Unsubscribe in one click.
Also filed as
- ALKEUS PHARMACEUTICALS INC (USCIS)
- Alkeus Pharmaceuticals, Inc (LCA)
Alkeus Pharmaceuticals, Inc H-1B: questions people ask
Does Alkeus Pharmaceuticals, Inc sponsor H-1B visas?
Yes — by its record, Alkeus Pharmaceuticals, Inc is a small-scale H-1B sponsor: it filed 3 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 3 USCIS H-1B petition approvals (1 for new employment). Its latest certified LCA in our data was decided Feb 9, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.
Is Alkeus Pharmaceuticals, Inc still sponsoring H-1B in 2026?
Alkeus Pharmaceuticals, Inc had 1 certified LCAs in FY2026 (Oct 2025–Sep 2026), fewer than the 2 in FY2025. The latest one in our data was decided Feb 9, 2026. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.
How many H-1B petitions does Alkeus Pharmaceuticals, Inc get approved?
USCIS recorded 3 approvals (1 for new employment, the rest continuing employment such as extensions and transfers) and 0 denials for Alkeus Pharmaceuticals, Inc in FY2024–FY2026 — a denial rate of 0.0%. Source: USCIS H-1B Employer Data Hub (first decisions).
What is the H-1B salary at Alkeus Pharmaceuticals, Inc?
The median wage offered on Alkeus Pharmaceuticals, Inc's certified LCAs in FY2024–FY2026 was $110k a year. By job title: Associate Director, GMP Quality Assurance $193k (1 LCAs), Senior Associate, Quality Management Systems $110k (1 LCAs) and Project Manager, Medical Affairs $92k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.
Which jobs does Alkeus Pharmaceuticals, Inc sponsor for H-1B?
Its certified LCAs in FY2024–FY2026 were mostly for Industrial Production Managers (1), Project Management Specialists (1) and Computer Systems Engineers/Architects (1).
Where are Alkeus Pharmaceuticals, Inc's H-1B jobs?
By worksite on its certified LCAs (FY2024–FY2026): Massachusetts (3).
Is Alkeus Pharmaceuticals, Inc an H-1B dependent employer?
No — its recent LCAs do not declare it H-1B dependent.
Does Alkeus Pharmaceuticals, Inc have open jobs?
Yes — 2 open US jobs on its own career site, re-checked every 1–3 days. Each job shows how often Alkeus Pharmaceuticals, Inc filed LCAs for that occupation.